- Home
- RZLT vs OSUR Comparison
RZLT vs OSUR Comparison
Compare RZLT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- OSUR
- Stock Information
- Founded
- RZLT 2010
- OSUR 2000
- Country
- RZLT United States
- OSUR United States
- Employees
- RZLT N/A
- OSUR N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- RZLT Health Care
- OSUR Health Care
- Exchange
- RZLT Nasdaq
- OSUR Nasdaq
- Market Cap
- RZLT N/A
- OSUR 223.0M
- IPO Year
- RZLT N/A
- OSUR 1986
- Fundamental
- Price
- RZLT $3.72
- OSUR $2.60
- Analyst Decision
- RZLT Strong Buy
- OSUR Hold
- Analyst Count
- RZLT 7
- OSUR 2
- Target Price
- RZLT $12.33
- OSUR $5.50
- AVG Volume (30 Days)
- RZLT 1.7M
- OSUR 444.5K
- Earning Date
- RZLT 05-19-2025
- OSUR 05-07-2025
- Dividend Yield
- RZLT N/A
- OSUR N/A
- EPS Growth
- RZLT N/A
- OSUR N/A
- EPS
- RZLT N/A
- OSUR N/A
- Revenue
- RZLT N/A
- OSUR $161,626,000.00
- Revenue This Year
- RZLT N/A
- OSUR N/A
- Revenue Next Year
- RZLT N/A
- OSUR $7.55
- P/E Ratio
- RZLT N/A
- OSUR N/A
- Revenue Growth
- RZLT N/A
- OSUR N/A
- 52 Week Low
- RZLT $2.22
- OSUR $2.69
- 52 Week High
- RZLT $6.19
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- RZLT 55.45
- OSUR 30.12
- Support Level
- RZLT $3.53
- OSUR $2.91
- Resistance Level
- RZLT $4.20
- OSUR $3.09
- Average True Range (ATR)
- RZLT 0.34
- OSUR 0.11
- MACD
- RZLT 0.04
- OSUR -0.02
- Stochastic Oscillator
- RZLT 62.99
- OSUR 26.47
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.